Only 4.2% of participants discontinued due to side effects after week 24, indicating excellent long-term tolerability
I truly appreciated their care and support
Therefore, we have suggested that doctors [do] not need to hold this medication from patients unless they have underlying eye conditions. Novo Nordisk, the maker of Ozempic, Wegovy and Saxenda, said patient safety is a top priority and that it continuously monitor[s] the safety profile of our medicines in collaboration with the TGA and other regulators worldwide
After propensity-score matching, the two cohorts (26,784 in each cohort, mean age 51.3 years, 65.6% women, 16.1% Black, 66.5% White, 6.7% Hispanic) were balanced (Table 1)
Some patients find that taking their GLP-1 injection at a specific time of day helps them manage side effects, though this is a pragmatic approach with uncertain benefit, particularly for weekly GLP-1 medications
Syndication Partners All syndication partners involved in the distribution of this publication are similarly protected from any liability related to the content